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Abstract 
 
Despite major advances in the study of glioma, the quantitative links between intra-
tumor molecular/cellular properties, clinically observable properties such as 
morphology, and critical tumor behaviors such as growth and invasiveness remain 
unclear, hampering more effective coupling of tumor physical characteristics with 
implications for prognosis and therapy.  Although molecular biology, histopathology, and 
radiological imaging are employed in this endeavor, studies are severely challenged by 
the multitude of different physical scales involved in tumor growth, i.e., from molecular 
nanoscale to cell microscale and finally to tissue centimeter scale. Consequently, it is 
often difficult to determine the underlying dynamics across dimensions.  New 
techniques are needed to tackle these issues.  Here, we address this multi-scalar 
problem by employing a novel predictive three-dimensional mathematical and 
computational model based on first-principle equations (conservation laws of physics) 
that describe mathematically the diffusion of cell substrates and other processes 
determining tumor mass growth and invasion.  The model uses conserved variables to 
represent known determinants of glioma behavior, e.g., cell density and oxygen 
concentration, as well as biological functional relationships and parameters linking 
phenomena at different scales whose specific forms and values are hypothesized and 
calculated based on in-vitro and in-vivo experiments and from histopathology of tissue 
specimens from human gliomas.  This model enables correlation of glioma morphology 
to tumor growth by quantifying interdependence of tumor mass on the 
microenvironment (e.g., hypoxia, tissue disruption) and on the cellular phenotypes (e.g., 
mitosis and apoptosis rates, cell adhesion strength). Once functional relationships 
between variables and associated parameter values have been informed, e.g. from 
histopathology or intra-operative analysis, this model can be used for disease 
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diagnosis/prognosis, hypothesis testing, and to guide surgery and therapy.  In particular, 
this tool identifies and quantifies the effects of vascularization and other cell-scale 
glioma morphological characteristics as predictors of tumor-scale growth and invasion.   
 
Introduction 
 
Generic molecular mechanisms and cell-scale migration dynamics are well described 
(Friedl & Wolf, 2003, Keller et al., 2006, Sierra, 2005, van Kempen et al., 2003, Wolf & 
Friedl, 2006, Kopfstein et al., 2006, Yamaguchi et al., 2005, Elvin & Garner, 2005, 
Sahai, 2005, Friedl et al., 2004, Friedl, 2004, Condeelis et al., 2005, Ridley et al., 2003) 
to the point that therapies designed with this knowledge have been recently employed 
to attempt to curtail or prevent growth and invasion of various cancers.  However, the 
effects of therapies are often inadequate or their benefits unclear. 3D culture and in-vivo 
studies of effects of cell-adhesion molecules (CAM) and matrix metallo-proteinases 
(MMP) on cell migration have yielded inconsistent results (Friedl & Wolf, 2003, Toker & 
Yoeli-Lemer, 2006, Khoshyomn et al., 1999, Giese et al., 1996), and data on the 
function of proteases in tumor invasion and metastasis are not completely as expected 
(Friedl & Wolf, 2003). Pharmacological inhibitors that regulate cell adhesion are being 
employed in anti-invasive therapy to treat various cancers (McLean et al., 2005, Yin et 
al., 2006, Lockett et al., 2006, Lah et al., 2006, Eble & Haier, 2006, Havot et al., 2006, 
Dervcke et al., 2005, Huang et al., 2005) with conflicting results (Lah et al., 2006). While 
recently approved anti-antiangiogenic drugs (e.g., bevacizumab) provide grounds for 
optimism for cancer treatment (Ellis & Kirkpatrick, 2005) the effect of antiangiogenic 
therapy on length of survival needs further investigation (Bernsen & van der Kogel, 
1999, Kuiper et al., 1998).  Anti-angiogenic treatment can exacerbate hypoxic effects 
(Steeg, 2003) and cause glioma mass fragmentation, cancer cell migration and tissue 
invasion (Rubenstein et al., 2000, Kunkel et al., 2001, Lamszus et al., 2003, Bello et al., 
2004).  Similar effects have been recently predicted by computer simulations for some 
chemotherapies (Sinek et al., 2004).  
 
These variable observations of tumor invasion and response to therapy illustrate the 
critical need for biologically realistic and predictive multi-scale theoretical models that 
quantitatively connect tumor proliferation and invasion with vascular density, blood flow, 
and micro-environmental substrate gradients. Indeed, it is clear from experience in the 
physical sciences that such complex systems, dominated by large numbers of 
processes and highly non-linear dynamics, are very difficult to approach by 
experimental methods alone and can typically be understood only using appropriate 
mathematical models and sophisticated computer simulations, in addition and 
complementary to laboratory and clinical observations (Cristini et al., 2006; Sanga et al., 
2007). Here we develop a computational (in-silico) model whose parameter values and 
mathematical functions can be informed based on experimental and clinical data to 
predict tumor prognosis and outcome, including glioma growth, neovascularization, and 
response to treatment.  This method is based on first principles (e.g., diffusion equation) 
and numerical algorithms that link the tissue scale tumor behavior to the underlying 
molecular biology by experimentally tested functional relationships between the 
molecular properties of tumor cells and the environment and tissue scale model 
parameters. Our central hypothesis is inspired by an engineering approach whereby 
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tumor lesions are viewed as a complex micro-structured material, where the three-
dimensional tissue architecture (“morphology”) and dynamics are coupled in complex, 
nonlinear ways to cell phenotype, and this to molecular factors and phenomena in the 
microenvironment acting both as tumor-morphology regulators and as determinants of 
the invasion potential by controlling the mechanisms of cancer-cell proliferation and 
migration (Friedl & Wolf, 2003) among the others.   
 
In our approach, we develop models of Functional Collective Cell-Migration Units 
(FCCMU) that describe the large-scale morphology and 3-D cell spatial arrangements 
during tumor growth and invasion and incorporate micro-macro functional relationships 
as described above.  This includes the application of mathematical and empirical 
methods to quantify the competition between cell substrate gradient-related pro-
invasion phenomena and molecular forces that govern proliferation and taxis, and 
forces opposing invasion through cell adhesion. The latter, under normoxic conditions, 
often enforce compact non-infiltrative tumor morphology while local oxygen gradients 
promote invasion (Steeg, 2003, Page et al., 1987, Seftor et al., 2002, Kunkel et al., 
2001, Pennachietti et al., 2003, Lamszus et al., 2003, Bello et al., 2004, Rubenstein et 
al., 2000, Rofstad & Halsor, 2000, DeJaeger & Kavanagh, 2001, Cristini et al., 2005, 
Frieboes et al., 2006, Macklin & Lowengrub, 2007).  Interactions between cellular 
proliferation and adhesion and other phenotypic properties may be reflected in both the 
surface characteristics, e.g., stability, of the tumor-host interface and the growth 
characteristics of tumors (Cristini et al., 2003, Cristini et al., 2005, Frieboes et al., 2006, 
Gatenby et al., 2006, Macklin & Lowengrub, 2007).  These characteristics give rise to 
various tumor morphologies and influence treatment outcomes.  The model thus 
enables the deterministic linking of collective tumor cell motion on the balance between 
cellular properties and the microenvironment.  In this paper, we focus on describing the 
gross morphologic behavior resulting from a typical glioma phenotype.  Direct links to 
the underlying genotype are studied elsewhere (Bearer and Cristini, manuscript 
submitted).   
 
We assemble this 3-D multiscale computational model of cancer as a key step towards 
the transition from qualitative, empirical correlations of molecular biology, 
histopathology, and imaging to quantitative and predictive mathematical laws founded 
on the underlying biology.  The model provides resolution at various tissue physical 
scales, including the microvasculature, and quantifies functional links of molecular 
factors to phenotype that currently for the most part can only be tentatively established 
through laboratory or clinical observation.  This mathematical and computational 
approach allows observable properties of a tumor, e.g., its morphology, to be used to 
both understand the underlying cellular physiology and predict subsequent growth (or 
treatment outcome), providing a bridge between observable, morphologic properties of 
the tumor and its prognosis  (Cristini et al. 2006; Sanga et al., 2007).   
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Method Overview  
 
The FCCMU model is based on conservation laws (e.g., of mass and momentum) with 
conserved variables that describe the known determinants of glioma (e.g., cell density) 
and with parameters that characterize a specific glioma tissue.  The conservation laws 
consist of well established, biologically founded convection-reaction–diffusion equations 
that govern the densities of the tumor cell species, the diffusion of cytokines and the 
concentration of vital nutrients. The model describes the cells’ (collective) migratory 
response and interaction with the extra-cellular matrix (ECM) and an evolving 
neovasculature. The collective tumor cell velocity depends on proliferation-driven 
mechanical pressure in the tissue, chemotaxis and haptotaxis due to gradients of 
soluble cytokines and insoluble matrix macromolecules.  The cell species velocity is 
obtained from a Darcy’s law coarse scale reformulation of the inertialess momentum 
equation, which is the instantaneous equilibrium among the following forces: pressure, 
resistance to motion (cell-adhesion), elastic forces, forces exchanged with the 
extracellular matrix (ECM) leading to haptotaxis and chemotaxis and other mechanical 
effects (e.g. Cristini et al., 2003, Zheng et al., 2005, Cristini et al., 2005, Frieboes et al., 
2006, Sanga et al., 2006, Li et al., 2007, Anderson & Chaplain, 1998, Anderson, 2005, 
Anderson et al., 2000, Chaplain & Lolas, 2005, Adam, 1996, Bellomo & Preziosi, 2000, 
Chaplain & Anderson, 2003, Friedman, 2004, Araujo & McElwain, 2003, Macklin & 
Lowengrub, 2005, Greenspan, 1976, Byrne & Chaplain, 1996a, 1996b, Ambrosi & 
Guana, 2006, Macklin & Lowengrub, 2007, Ambrosi & Preziosi, 2002, Byrne & Preziosi, 
2003, Chaplain et al., 2006).  Cells produce proteases, which degrade the matrix locally, 
making room for cells to migrate. In the model, matrix degradation releases cytokines 
and growth promoters, thus having biological effects on tumor cells (e.g., Chaplain & 
Anderson, 2003). The model can account for cell-cell interactions (cell-cell adhesion 
and communications), high polarity, and strong pulling forces exchanged by cells and 
ECM (Friedl & Wolf, 2003).  
 
The FCCMU model is coupled nonlinearly to a hybrid continuum-discrete, lattice-free 
model of tumor-induced angiogenesis (Plank & Sleeman, 2003, 2004). The 
angiogenesis component describes proliferation and migration due to chemotaxis and 
haptotaxis of endothelial cells in response to tumor angiogenic regulators (e.g. VEGF) 
and matrix macromolecules, respectively. The angiogenic regulators are released by 
perinecrotic tumor cells and host cells near the tumor-host interface (Takano et al., 
1996, Shweiki et al., 1999), which stimulate vascular endothelial cells of the brain 
vasculature to proliferate and begin to form vessels (Jain, 2003). Anastomosed vessels 
may provide a source of nutrient in the tissue and may undergo spontaneous shutdown 
and regression during tumor growth (Holash et al., 1999b). We note that there are other 
related lattice-based models of tumor neovascularization (e.g. Sun et al., 2005, 
McDougall et al., 2006). Although tumor angiogenesis may occur via the formation of 
sprouts or intussuception (Patan et al., 2001b), for simplicity here only the former 
process is incorporated in the model. Input parameter values to the model, e.g., cell 
proliferation and apoptosis, are estimated from in-vitro cell lines and ex-vivo patient 
data.  The parameters governing the extent of neovascularization and nutrient supply 
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due to blood flow are estimated in part from Dynamic Contrast Enhanced Magnetic 
Resonance Imaging (DCE-MRI) observations in patients (O’Connor et al., 2007).  
 
The FCCMU model describes nutrient/oxygen delivery from the neo-vasculature (via 
convection and diffusion (Chaplain, 1996, Jain, 2001)) and cellular uptake, and nutrient, 
oxygen, and growth factor diffusion through the tumor tissue (Byrne & Chaplain, 1997). 
Oxygen/nutrient availability limits the fraction of cycling cells. Regions of tissue become 
hypoxic and then necrotic where nutrient/oxygen concentration falls below a threshold. 
The model describes evolution of local mass fractions of viable tumor species, necrotic 
and host tissues. Cell mass exchange occurs due to mutations, mitosis, necrosis, and 
apoptosis. Lysis rates describe the disintegration of tumor cell mass and the radial 
effusion of fluid away from the necrotic regions. All rates are inverse times (unit time=1 
day).  
 
By solving the nonlinearly coupled FCCMU/angiogenesis equations numerically we 
predict the combination of variables most likely to lead to growth and invasion, such as 
nutrient and angiogenic regulator concentrations and diffusion rates; rates of 
proliferation, apoptosis and nutrient consumption; genotypic mutations in oncogenes, 
tumor suppressors, and migration-associated genes. At any given time during tumor 
growth, the model outputs the computed values of all relevant variables at every 
location within the three-dimensional tumor tissue, e.g., the spatial distributions of 
oxygen, nutrients and tumor cell species.  The result is a description of the complex, 
multi-scalar dynamics of in-vivo 3-dimensional tumors through avascular, neo-vascular, 
vascular growth, and invasion stages.  
 
 
Summary of Materials & Equipment Used  
 
Histopathology of human glioma.  Four archived autopsied brains obtained from the 
Brown University-Rhode Island Hospital Brain Bank were examined in haemotoxylin-
eosin stained paraffin sections prepared according to standard autopsy procedures. 
Autopsied diagnosis of glioblastoma multiforme was confirmed by two 
neuropathologists, and morphology at the tumor margins imaged on a Zeiss AxioImager 
by standard bright field and by fluorescence using FITC and rhodamine filters. Selective 
fluorescence in the rhodamine channel of hemoglobin in red blood cells combined with 
autofluorescence of connective tissue in the FITC channel greatly enhances detection 
of vasculature patterns in H&E sections of archived material (Bearer, unpublished 
methodology). 
 
Multiscale Model.  The minimal formulation of the FCCMU model is based on reaction-
diffusion equations that govern a tumor cell density, an evolving neovasculature, a vital 
nutrient concentration, the ECM, and matrix degrading enzymes. Extensions to include 
more complex biophysics, e.g., multiple nutrients, growth inhibitors and matrix 
remodeling, are straightforward. 
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In our approach, each constituent moves with its own velocity field; mass, momentum 
and energy equations are posed for each constituent. Through experimental 
comparisons and the inclusion of molecular-scale effects, we formulate functional 
relationships that close the FCCMU model. Generically, the reaction-diffusion equations 
take the form  
 
tv + -= -Ñ + G - GJg ,      (1) 
 
where v is the evolving variable, J is the flux, +G and -G  are the sources and sinks. 
Letting , , ,iv f mr s= , respectively be the tumor cell density of species i or host density, 
the vital nutrient concentration (e.g. oxygen), the (nondiffusible) matrix macromolecule 
(e.g. fibronectin (Anderson & Chaplain, 1998, Anderson, 2005)), and matrix degrading 
enzyme, MDE (e.g. matrix metalloproteinases, urokinase plasminogen activators 
(Anderson et al., 2000, Anderson, 2005, Chaplain & Lolas, 2005) concentrations, we 
may take 
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where ui is the cell-velocity of species/host i, wu is the velocity of water (i.e. assuming 
transport of chemical factors is primarily through the interstitial liquid), the D’s are 
diffusion constants, and ,deg , ,deg, , , , , ,prolif death blood uptake f f rade mde mde radel l l l l l l l  are the mitosis, 
apoptosis and necrosis, blood-tissue nutrient transfer and uptake and decay rates, 
respectively, for matrix molecules and MDE. An additional equation (not shown) is 
posed for the mass fraction of water. The flux Jmechanics,i accounts for the mechanical 
interactions among the different cell species. A major component of the FCCMU model 
is the development of the constitutive law for Jmechanics,I. This is obtained from a 
variational approach from an energy formulation that accounts for the mechanical 
forces, e.g. cell-cell and cell-matrix adhesion, and elastic effects (residual stress). A 
feature of this approach is the incorporation of a novel continuum model of adhesion in 
this flux. Following the variational approach developed for diffuse interface models of 
multiphase flows and materials by Lowengrub and coworkers (e.g., Lowengrub & 
Truskinovsky, 1998, Leo et al., 1998, Lee et al., 2002, Kim et al., 2004a, Kim et al., 
2004b, Wise et al., 2004, Kim & Lowengrub, 2005) and others (e.g. Garcke et al., 2004, 
Jacqmin, 1999, Anderson et al., 1998) we introduce a continuum model of cell-cell and 
cell-matrix adhesion energy which can be written as an integral taken over the entire 
tumor/host domain 2 2, 1 ,
1
1
( ,.., ) | |
2
N
adhesion i i N i j j
j
E f dxr r e r
=
= + Ñåò . The first term is a bulk 
energy, which accounts for the degree of miscibility of cell and host species, as directed 
by experiments. The second term introduces cell-cell adhesion forces that generate a 
surface tension between the phases and further accounts for intermixing across a 
diffuse interface of thickness that roughly scales with ei,i. Typically, the cell-adhesion 
energy enforces phase separation of tumor and host tissues sharing a diffuse interface 
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with thickness 1-100 mm. Under the assumption that tumor cells prefer to stay bonded 
with each other rather than being in any other configuration, that the cell density is 
roughly constant and that there is only isotropic stress (pressure p), this reduces, in an 
asymptotic limit, to the “jump” boundary condition[ ]p tk=  where t measures the affinity 
and k  is the total curvature of the interface (Wise et al., Frieboes et al., manuscripts 
submitted). This is akin to surface tension in multiphase flows and can also be used to 
describe tumor encapsulation by ECM fragments and is characteristic of collective cell 
migration (Friedl & Wolf, 2003). 
 
A thermodynamically consistent constitutive law for the flux Jmechanics,I  is obtained by 
taking the gradient of the variational derivative of the total energy: 
( )mechanics, mechanics,i i iEd drµ ÑJ , where Emechanics,I is obtained by adding the contributions 
from each mechanism modeled, i.e. adhesion, elasticity, etc. The velocities ui and wu  
are determined from momentum equations. For example, following previous 
approaches (e.g., Cristini et al., 2003, Zheng et al., 2005, Cristini et al., 2005, Frieboes 
et al., 2006, Li et al., 2007, Macklin & Lowengrub, 2005, Macklin & Lowengrub, 2007) 
that are reformulations and generalizations of models in (Greenspan, 1976, Byrne & 
Chaplain, 1996a, 1996b, Adam, 1996, Bellomo & Preziosi, 2000, Chaplain & Anderson, 
2003) and neglecting viscoelastic effects, we take Darcy’s law as a coarse scale 
reformulation of the inertialess momentum equation, which is the instantaneous 
equilibrium among the following forces: pressure, resistance to motion, elastic forces, 
forces exchanged with the ECM leading to hapto- and chemo- taxis and other 
mechanical effects within Emechanics as discussed above. This leads to  
 
( ), , ,/i i i mechanical i i i f i iM p E f sg d dr r c c s= - Ñ + Ñ + Ñ + Ñu        (3) 
 
where p is the pressure (isotropic stress) and M , ig , fc  and sc are the spatially 
inhomogeneous mobility, mechano-, hapto- and chemo- taxis tensors that also take into 
account cell-matrix adhesion. The parameter M depends on the extent of cell-to-cell and 
cell-to-ECM adhesion in bulk regions. Since a number of different parameters in the 
model describe various effects of cell-cell and cell-ECM adhesion it is expected that this 
model should have enough complexity to reproduce nontrivial and non-monotonic 
dependences of migration on CAMs (Friedl & Wolf, 2003). Note that other models such 
as Stokes, viscoelastic and nonlinear-elastic/plastic can be incorporated as required.  
 
The FCCMU continuum-scale convection-reaction-diffusion equations are solved 
numerically using a novel adaptive finite-difference  method (Wise et al., Frieboes et al., 
manuscripts submitted). This method features an adaptive, block-structured Cartesian 
mesh refinement algorithm (e.g. Berger & Colella, 1989), centered differences in space 
and an implicit time discretization for which there is no stability constraint on the space 
and time steps. The nonlinear equations at the implicit time level are solved efficiently 
using a multilevel, nonlinear multigrid method (e.g. Brandt, 1977). A typical simulation 
(e.g. Fig. 1) required two days of CPU time on a Xeon processor with 3.06 GHz and 2 
GB of RAM. 
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Tumor Vasculature.  We model the physiology and evolution of glioma neovasculature 
in 3D using a hybrid continuum-discrete, lattice-free model of tumor angiogenesis which 
is a refinement of earlier work (Plank & Sleeman, 2003, 2004). This was shown to 
create dendritic structures consistent with experimentally observed tumor capillaries 
(Less et al., 1991, Skinner et al., 1990).  This random-walk model generates vascular 
topology based on tumor angiogenic regulators, e.g., vascular endothelial growth factor 
(VEGF) (Takano et al., 1996), represented by a single continuum variable that reflects 
the excess of pro-angiogenic regulators compared to inhibitory factors. Peri-necrotic 
tumor cells and host tissue cells close to the tumor boundary are assumed to be a 
source of angiogenic regulators (e.g., VEGF). Endothelial cells near the sprout tips 
proliferate and their migration is described by chemotaxis and haptotaxis (e.g., motion 
up gradients of angiogenic regulators and matrix proteins such as fibronectin).  For 
simplicity, only leading endothelial cells are modelled and trailing cells passively follow.  
The vasculature architecture, i.e., interconnectedness and anastomoses, is captured via 
a set of rules, e.g., a leading endothelial cell has a fixed probability of branching at each 
time step while anastomosis occurs if a leading endothelial cell crosses a vessel trailing 
path.  Glioma vessels are more tortuous than normal vessels (Bullitt et al., 2005).  This 
can be quantified by various means including a “Sum of Angles Metric” (SOAM) that 
sums total curvature along a space curve and normalizes by path length, indicating high 
frequency, low-amplitude sine waves or coils (Bullitt et al., 2005).  
 
The tumor-induced vasculature does not initially conduct blood, as the vessels need to 
form loops first (anastomosis) (Augustin, 2001).  As observed experimentally, the 
neovasculature model may also account for increasing vessel diameters and 
spontaneous shutdown and consecutive regression of initially functioning tumor vessel 
segments or whole microvascular areas (Holash et al., 1999b). Here, functional 
anastomosed vessels were assumed to provide a source of nutrient in the tissue 
proportionally to local pressure. 
 
Calculation of model parameters. Previous measurements of growth and histology of 
in-vitro ACBT (human glioblastoma multiforme) tumor spheroids (Frieboes et al., 2006), 
and of human glioma (Bearer and Cristini, manuscript submitted) were used to inform 
the parameters of the simulation presented herein.  Briefly, higher-grade glioma mitosis 
and apoptosis rates were taken to be 1 day-1 and 0.32 day-1 respectively. The 
characteristic time scale was taken to be the inverse mitosis rate. The diffusion 
penetration length was measured to be100 mm (Cristini et al., 2003, Frieboes et al., 
2006), and is used herein as the characteristic unit of length. The necrosis threshold 
was taken to be sN/sV =0.5, where sN is the nutrient concentration needed for viability 
and sV is the nutrient concentration in the far-field. Mutation rates from low to high 
grade glioma were also estimated in previous work (Bearer and Cristini, manuscript 
submitted) but not utilized here. In previous work, a critical value of cell adhesion 
parameter was determined from shape stability analysis of experimental and simulated 
spheroids (Frieboes et al., 2006): compact spherical morphologies exist only for 
sufficiently large adhesion, which is implemented via the parameter ig (after non-
dimensionalization) in equation (3). The above set of parameters provided the baseline 
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for our simulations (Fig. 1 shows a simulation using a sub-critical value of the adhesion 
parameter). Simulations were performed using one fixed set of parameters as described 
above. Parameter sensitivity studies were performed where cell adhesion ( ig ) and cell 
chemotaxis ( ,isc ) parameters were varied to study their effect on the morphology of 
infiltrating collective-cell patterns (i.e., cell chains vs. strands vs. detached clusters 
(Friedl & Wolf, 2003)). Representative resulting morphologies are reported elsewhere 
and confirm that for relatively low cell adhesion morphologic instability occurs when 
nutrient heterogeneity is present leading to the development of infiltrative cell 
protrusions (Cristini et al. 2003, Frieboes et al., 2006, Macklin & Lowengrub 2007; 
Bearer and Cristini, manuscript submitted). The shape features of these protrusions 
further depends on the relative strengths of cell proliferation and cell chemotaxis. A 
control was provided by simulations corresponding to relatively high cell adhesion, for 
which tumors grow spherical and morphologic instability does not occur.  
 
Complex tissue structure. To model complex tissue structures, an additional variable 
S is introduced to model the local structure of the tissue. For example, in the simulation 
described below, we take S =1 where there is bone (e.g. cranium). We then take the 
mobility, mechano-, hapto- and chemo- taxis tensors M , ig , fc  and sc  to be spatially 
inhomogeneous such that that these tensors (assumed to be isotropic in the simulation 
below) are small in regions where S is approximately equal to 1. In the attached movie, 
we simulate an aggressive tumor growing in a 1.3 cm square of brain tissue (upper left 
frame), which includes white matter (lightest gray), gray matter (medium gray), bone 
(white), external blood vessels (darkest gray), and fluid (black) in the folds of the 
cerebral cortex. As the tumor grows, oxygen levels drop (upper right frame), leading to 
hypoxia (blue regions in upper left frame), the secretion of pro-angiogenic growth 
factors (lower right frame), and necrosis (brown regions in the upper left frame).  
 
The tumor response to oxygen availability leads to pressure variations. During the early 
period of rapid growth, pressure increases in the tumor and the surrounding tissue. 
Later, volume loss in the necrotic core moderates the pressure. (See day 10.) The 
inhomogeneous necrotic volume loss leads to morphological instability, seen in the 
formation of rapidly developing buds that invade the surrounding tissue and increase 
the pressure. (See days 20 to 30.) Thereafter, we see a cyclic pattern of rapid 
proliferation and pressure buildup, followed by necrosis-induced pressure relief. The 
tissue geometry plays a critical role in this process. Tumor buds invading the white 
matter (top of the tumor) encounter less mechanical resistance, leading to the formation 
of relatively slender invasive fingers, compared to the blunt bulbs invading the gray 
matter. The tumor buds also rapidly elongate and grow along the folds of the cortex 
where the tumor cells are highly mobile. As the tumor continues to grow, pressure 
builds between the tumor and the cranium, which retards the growth of the tumor 
towards the skull in spite of ample oxygen and nutrients (top right frame).  
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Results  
 
The 3-D multiscale model correctly predicts gross morphologic features of growing 
tumors (Fig. 1).  (A movie of this simulation is in Supporting Online Material.) Figure 1A 
shows a mm-sized glioblastoma during early stages of growth simulated using our 3-D 
multiscale model.  The model predicts regions of viable cells, necrosis in inner tumor 
areas, and a tortuous neovasculature as observed in vivo (Bullitt et al., 2005).  The 
vessels labeled in red are capable of releasing nutrient. The rate of nutrient released 
may depend on their age and the solid pressure in the tissue. The vessels migrate 
towards the tumor/host interface since peri-necrotic tumor cells and host tissue cells 
close to the tumor boundary are assumed to produce angiogenic factors and other 
regulators. The tumor eventually coopts and engulfs the vessels. The tumor-induced 
vasculature does not initially conduct blood, as the vessels need to form loops first 
(anastomosis) (Augustin, 2001), i.e., more mature vessels that have anastomosed 
conduct blood and may release nutrient.  By hypothesizing the underlying mechanisms 
driving these phenomena, the model enables a quantitative analysis, e.g., viable region 
thickness of about 100-200 mm and extent of necrosis as seen in Fig. 1 B are shown to 
be strongly dependent on diffusion gradients of oxygen/nutrient in the microenvironment 
and agree with previous experiments (Helmlinger et al., 1997, Frieboes et al., 2006). 
Chaotic angiogenesis leads to heterogeneous perfusion in the tumor that then might be 
responsible for regression of parts of the vascular network and necrosis of tumor cells 
(Carmeliet & Jain, 2000, Patan et al., 2001b), further enhancing variable tumor cell 
proliferation.    By taking vessel maturation into account, the simulations correctly 
predict that as tumor size increases, inner vessels may regress or shut down, leading to 
nutrient depletion and resulting in the formation of a large necrotic core (data not 
shown), as observed in patients.  For example, cm-sized human glioblastoma at later 
stages as seen through Magnetic Resonance Imaging (MRI) in patients (e.g., Wurzel et 
al., 2005) is composed of viable cells delineating its boundary and surrounding 
extensive necrosis in its inner region. 
 The multiscale model enables the prediction of tumor morphology by quantifying 
the spatial diffusion gradients of cell substrates maintained by heterogeneous cell 
proliferation and an abnormal, constantly evolving vasculature.  Figure 1A,C shows a 
simulated time-sequence over the course of three months predicting that the 
glioblastoma grows with a thin layer of viable tissue on its periphery, displacing nearby 
tissue and internally generating necrosis. The morphology is directly influenced by 
angiogenesis, vasculature maturation, and vessel cooption (Vajkoczy et al., 2002, 
Augustin, 2001, Holash et al., 1999a).  The model predicts that the tumor boundary 
moves at a rate of about 50-100 mm per week, presenting a mass of diameter of about 5 
cm in one year (data not shown). These results are supported by well-known clinical 
observations (e.g., Naganuma et al., 1989).  As the tumor grows and engulfs vessels in 
its vicinity, the tumor may compress the vessels (Padera et al., 2004) and disrupt flow of 
nutrients, leading to further necrosis and even temporary mass and vascular regression 
(Zagzag et al., 2000, Holash et al., 1999b).  The crucial role of cell substrate gradients 
on tissue structure and tumor invasion is further analyzed below (Figures 2 and 3).  
Figure 1B shows a histology-like section of the last frame of the simulation in Fig. 1A, 
obtained by slicing horizontally through the simulated tumor.  Viable tumor regions 
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(white) surround necrotic tissue (dark), as seen in vivo in MRI (e.g., Wurzel et al., 2005) 
and ex-vivo in histopathology (see below). 
 A growing tumor contends with increasing mechanical resistance from normal 
brain tissue, which has physical properties resembling a gel (Ommaya, 1968, 
Fallenstein et al., 1969).  Nevertheless, this resistance is insufficient to contain tumor 
growth, e.g., gliomas have been observed to displace cartilage (Kumar et al., 2003).  
Only hard bone (e.g., the skull) will be a physical barrier.  The effect of such physical 
barriers on tumor morphology and growth can be incorporated in the multiscale model 
(see Summary of Materials & Equipment Used). 
 
Tumor structure and morphology is significantly affected by diffusion gradients, e.g., of 
oxygen and nutrients, in the cellular microenvironment (Figure 2).  The computer model 
(histology-like sections of the last frame of the simulation in Fig. 1A, obtained by slicing 
vertically through the simulated tumor) predicts that viable regions of thickness of about 
100-200 mm encircle the neo-vessels (Kunkel et al., 2001), with acellular (necrotic) 
areas in between them, thereby determining the tumor tissue architecture (Fig. 2 A) 
based on the diffusion limit for cell substrates (Fig. 2 B) (Helmlinger et al., 1997).  As a 
consequence, overall tumor shape is also determined by the distribution of vessels 
(Figure 2 A). These results are supported by numerous experimental observations in 
animal glioblastoma models (Rubenstein et al., 2000, Kunkel et al., 2001, Lamszus et 
al., 2003, Bello et al., 2004), and from histopathology of brain tumors in patients, and 
may also apply to solid tumors in general (Cristini et al., 2005, Frieboes et al., 2006) 
beyond the context of brain tumors.  A histology section of glioblastoma from a patient 
(Figure 2 C) reveals a bulb-shaped group of cells with evident internal vascularization 
and tissue structure that supports the predictions of the computer model (Fig. 2A, B). 
Note that overall computed tumor shape (Fig. 2A) is different from that in the patient 
(Figure 2 C) as the tumor shapes are dictated by the (relatively random) distribution of 
vessels. However, the internal tissue structures of the computed and in vivo tumors are 
similar as set by (deterministic) diffusion gradients of cell substrates.  
 
The computer model predicts that substrate diffusion gradients strongly affect tumor 
invasion in addition to tumor and host tissue morphology and structure (Figure 3).  In-
silico histopathology of a computer simulation shows that glioma cells may rely on 
vessels beyond the tumor boundary—and grow towards blood vessels in the host tissue 
that they contribute to stimulate (Figure 3 A) (Bartels et al., 2006, Preusser et al., 2006).  
The simulation illustrates an invasive front of tumor cells collectively moving up towards 
the neovasculature, revealing the dramatic effect of cell substrate gradients on the 
tumor morphology and invasion beyond molecular-scale signaling events (Tysnes & 
Mahesparan, 2001). The dynamics of this invasion mechanism, termed “diffusional 
instability,” have been studied elsewhere (Cristini et al. 2003, Cristini et al., 2005, 
Frieboes et al., 2006, Macklin & Lowengrub 2007). Representative histologic sections 
from four examples of glioblastoma multiforme in patients also reveal protruding fronts 
of cells in collective motion away from necrotic areas, up gradients of cell substrates, 
into areas of the brain where neo-vascularization is evident and strongly resembling 
tumor boundary morphologies predicted by the computer simulations. Figure 3 B 
provides a more detailed image of a glioblastoma histology section from a patient that 
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reveals a tumor front (bottom) pushing into the healthy brain tissue (top).  Normal brain 
(white matter) has fewer cell bodies and more abundant amorphous matrix.  Invading 
malignant astrocytes (in the middle) have pleiomorphic nuclei and an irregular 
distribution. Note clearly demarcated margin between tumor and normal brain tissue, as 
well as green fluorescent outlines of more mature vascular channels deeper in the 
tumor.  Neovascularization at the tumor-brain interface is readily detected by red 
fluorescence from erythrocytes inside the vessels. These vessels generate substrate 
diffusion gradients across the tissue, which in turn drive collective tumor cell infiltration 
into the brain. More mature vessels within the tumor may be compressed which may 
restrict the blood flow.  Here this is shown by relative lack of red fluorescence from 
RBCs in the deeper tumor vessels as compared to the vessels in the brain at the tumor 
margin.  This, together with vessel aging, may also reduce the vessel permeabilty for 
nutrient/oxygen exchange between the vessels and the tissue (Padera et al., 2004), 
further promoting substrate gradients pointing outwards from the tumor mass.   
 
Figure 4 shows the anatomic features of the tortuous tumor vasculature as simulated by 
the multiscale model (Figure 4A) and as seen in vivo (Bullitt et al., 2005) (Figure 4 B), 
enabling both qualitative and future quantitative analyses.  In the model, the vasculature 
structure, e.g., tortuosity and tumor vessel location, is influenced by intermittent tumor 
tissue hypoxia coupled to both endothelial and tumor cell chemo- and hapto-taxis as a 
function of diffusion gradients of growth factors and other substances in the 
microenvironment (Li et al., 2000, Bullitt et al., 2005).  
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Discussion 
 
We have performed, for the first time to our knowledge, 3-D computer simulations of 
growing glioma and neovascular morphologies as predicted by a multiscale 
mathematical model based on first principles and informed by experimental and clinical 
data, e.g., histopathology data transformed into model input parameters, and calibrated 
so that tumor morphology can be predicted beyond a purely empirical, observational 
approach.  Results of glioma morphology, growth, and vascularization obtained through 
the model are also supported by previous experimental and in vivo studies.  Although 
high-grade gliomas are highly angiogenic and this characteristic correlates with clinical 
progression (Boegler & Mikkelsen, 2003), microvascular inadequacy may induce 
necrosis, drive glioma cells to aggressively invade adjacent tissue in vivo (Vajkoczy et 
al., 2002), and trigger angiogenic sprouting from the surrounding microvasculature (as 
seen in the simulation in Figure 1A, left).  By the second week after implantation in an 
animal model, gliomas had established their own vasculature and were maintaining it 
through continued angiogenic sprouting from both host and tumor vessels (Vajkoczy et 
al., 2002), as is also observed with other tumors (Li et al., 2000).  Although some cells 
showed a strong affinity for the perivascular space of host vessels, the bulk of the tumor 
did not move towards cerebral vessels.  Within one week, adjacent host vessels lost the 
brain-blood barrier, dilated, increased in tortuosity, and produced vascular sprouts, 
which penetrated the tumor mass and formed the initial tumor neovasculature, in 
agreement with our results (Figure 1A, middle).  The computer model can 
accommodate the increase in new tumor vessel diameter (about 1.5x) during a period of 
2 weeks, as seen in vivo (Vajkoczy et al., 2002).  The model implements a tumor vessel 
maturation period of 3 weeks that agrees with common physiological models of vessel 
formation (Cai et al., 2004, Patan et al., 2001a, Cursiefen et al., 2006), and 
hypothesizes that an evolving vasculature will affect a growing tumor through 
heterogeneous perfusion (Bernsen et al., 1995), vascular network regression, and 
tumor cell necrosis, based on in vivo observations (Patan et al., 2001b).  The 
neovasculature is chaotic, of heterogeneous angio-architecture, has large caliber 
vessels and sluggish blood flow.  While undergoing constant remodeling, the 
neovasculature is also characterized by spontaneous shutdown and consecutive 
regression of initially functioning tumor vessel segments or whole microvascular areas, 
thus maintaining strong diffusion gradients in the microenvironment and directly 
affecting tumor morphology.  This effect is dramatically seen through the model in 
Figure 1A, right and Fig. 1 C.  In this scenario, the tumor grows avascularly first, either 
coopts the existing vasculature or forms a new one, and then becomes necrotic as this 
vasculature undergoes regression, leading to new cycles of angiogenesis and growth.  
Vascular regression associated with the onset of necrosis in the tumor, followed by 
further angiogenesis at the tumor margins was also observed experimentally (Holash et 
al., 1999b).   
 
The multiscale model predicts that glioma tissue structure and tumor invasiveness are 
significantly influenced by diffusion gradients in the microenvironment, as observed 
experimentally (Rubenstein et al., 2000, Kunkel et al., 2001, Lamszus et al., 2003, Bello 
et al., 2004, Frieboes et al., 2006) and in human patients (Bearer and Cristini, 
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manuscript submitted).  These gradients may have a strong effect on glioma 
morphology (Cristini et al., 2005, Macklin & Lowengrub, 2007), and are hypothesized in 
the model to reciprocally influence a growing tumor’s continuously evolving vasculature 
in complex ways.  The 3-D model facilitates this study by calculating the chemotactic 
and haptotactic response of the blood vessels at the cell scale (see Summary of 
Materials & Equipment Used) and its cumulative effect at the tumor scale (Figure 4A).   
 
Glioma invasion introduces barriers to tumor resection and to therapy, and even when 
resection is an option, accurate prediction of the lesion’s invasive potential could help 
decide on a case-by-case if resection is indeed the best option and the optimal volume 
of lesion to be removed, thus directly impacting the grim outlook of this disease.  The 
multiscale model proposed herein could be of benefit to develop novel intervention 
strategies and better understand current ones.  By modeling tumor behavior in response 
to chemotherapeutic drugs whose target is known, outcomes may be predicted for 
individual patients.  In addition, experiments in silico using this modeling algorithm may 
also serve as test-beds for drug development thereby avoiding any need initially for 
clinical efficacy testing in real people. 
 
With its predictive capability, the model can be used to understand and predict growth, 
as well as the outcome of different therapies, thereby aiding in the selection of patient-
specific treatment.  Furthermore, because the underlying molecular and cellular biology 
are complex, the targets available for intervention strategies and their combinations are 
virtually infinite.  The parameter space can be searched using the mathematical model 
to identify critical parameters or combinations of parameters to sharpen the 
experimental focus (Cristini et al., 2006).  The advanced state of this modeling 
technology, coupled with the availability of high performance computing, enables us to 
propose that it is time to start integrating and further developing this methodology with 
therapeutic practice.  We envision that future computer simulators will build on the 
developments and findings of studies such as this one to complement current clinical 
practice, and to design novel minimally or non invasive treatment strategies aimed at 
achieving therapeutic cell kill levels while preventing invasion.  
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Figure 1. Multiscale 3-D computer model predicts gross morphologic features of a 
growing glioblastoma. (A movie of this simulation is in Supporting Online Material.)  A: 
Viable (VT) and necrotic (NT) tissue regions, and vasculature (MV: mature blood-
conducting vessels in red; NV: new non-conducting vessels in blue) are shown.  The 
time sequence (from left to right, over a period of 3 months) reveals that the morphology 
is affected by successive cycles of neovascularization, vasculature maturation, and 
vessel cooption (VC).  Bar, 250 mm. B: Histology-like section of the last frame of the 
simulation in A (obtained by slicing horizontally through the simulated tumor) reveals 
viable tumor regions (white) surrounding necrotic tissue (dark).  Tumor mass spatial 
distribution is calculated using Eq. 1 with v r=  and cell viability as a function of nutrient 
v s= . Input parameters were calibrated from in-vitro and ex-vivo glioma data (Summary 
of Materials & Equipment Used). In particular, tumor cells are estimated to proliferate at 
a rate prolifl =1 day
-1 (Frieboes et al., 2006). C: Another view from simulation shown in 
Fig. 1A, right.   
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Figure 2.  Multiscale model predicts that tumor tissue morphology is determined by 
diffusion gradients.  A: Tumor histology predicted by the computer model (obtained by 
slicing vertically through the simulated tumor corresponding to last frame in Fig. 1A) 
reveals clusters of viable cells (VT) surrounding blood vessel cross-sections (MV), and 
zones depleted of cells or necrotic farther away (NT). Viable tissue is confined within 
100-200 mm of the conducting intra-tumoral vessels and of the brain parenchyma (cross 
sections of conducting vessels are in red, non-conducting in blue). Bar, 200 mm. B: 
Calculated diffusion gradients of cell substrates corresponding to the tumor structure 
predicted by the simulation in A indicate high nutrient (white) in the vicinity of blood 
conducting vessels and low nutrient (black) otherwise, thereby determining the regions 
of cell viability. Legend: arbitrary units.  C: Glioblastoma histologic section from a patient 
shows tissue structure of a large bulb-shaped tumor area. This morphology reveals 
viable cells (VT) cuffing and surrounding blood vessels in cross-sections (MV), and 
depleted inter-vessel zones (NT). The thickness of the cuff of viable cells corresponds 
to the diffusion gradient of oxygen and nutrients they require emanating from the vessel. 
These results indicate that tumor architecture in this specimen is determined by cellular 
metabolism and intra-tumoral diffusion gradients of required nutrients provided by the 
vasculature, also confirming the presence of substrate gradients and the parameter 
estimates for diffusion length used in the simulations (Summary of Materials & 
Equipment Used). Bar, 200 mm. 
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Figure 3.  Multiscale model predicts that tumor tissue invasion is driven by diffusion 
gradients.  A: Detail of computer simulated glioma histology (obtained by slicing through 
the 3-D simulated tumor of Fig. 1) showing invasive tumor front (white) moving up 
towards extra-tumoral conducting neo-vessels (NV), supporting the hypothesis that 
diffusion gradients of cell substrates released by the neovasculature drive collective 
tumor cell infiltration into the brain in addition to determining the tumor structure (Figure 
2).  The model predicts that the movement of tumor fronts towards sources of cell 
substrate strongly influences glioma invasiveness.  Aged vessels inside the tumor have 
thicker walls and thus are assumed to provide fewer nutrients than the thin-walled 
neovasculature at the tumor periphery (Padera et al., 2004).  Conducting vessels (red), 
non-conducting (blue).  Bar, 100 mm. B: Glioblastoma histopathology from one patient 
showing tumor (bottom) pushing into more normal brain (top). Note demarcated margin 
between tumor and brain parenchyma to the middle top of the image and green 
fluorescent outlines of large vascular channels deeper in the tumor. Neovascularization 
(NV) at the tumor-brain interface can be detected by red fluorescence from the 
erythrocytes inside the vessels (see materials and methods for microscopic imaging of 
archived tissue in H&E by fluorescence). Bar, 100 mm. 
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Figure 4.  Anatomic features of glioma vasculature predicted by a simulation (A), 
highlighting the tortuous nature of the tumor vessels (conducting vessels in red, non-
conducting in blue), and observed in vivo (adapted with permission from Bullitt et al. 
(2005)) (B).  The multiscale model predicts that the vasculature is heavily influenced by 
diffusion gradients of cell substrates driving heterogeneous tumor cell proliferation and 
concomitant expression of angiogenic regulators. 
 
